Triple

T22662114
Position Surface form Disambiguated ID Type / Status
Subject ICH E2D E559691 entity
Predicate relatedTo P37 FINISHED
Object ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting | Statement: [ICH E2D, relatedTo, ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
Context triple: [ICH E2D, relatedTo, ICH E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting]
  • A. ICH E2A Clinical Safety Data Management chosen
    ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.
  • B. Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs
    Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs (ICH E2C) is an international guideline that standardizes the format, content, and timing of periodic safety reports submitted by marketing authorization holders to monitor and communicate the ongoing safety profile of approved medicines.
  • C. International Council for Harmonisation guideline E2C
    International Council for Harmonisation guideline E2C is a regulatory framework that provides standardized requirements for the ongoing safety evaluation and periodic benefit-risk assessment of marketed medicinal products.
  • D. ICH E9 Statistical Principles for Clinical Trials
    ICH E9 Statistical Principles for Clinical Trials is an international guideline that defines key statistical concepts and methodologies to ensure the design, analysis, and interpretation of clinical trial data are scientifically sound and regulatory compliant.
  • E. Clinical Trials Information System
    The Clinical Trials Information System is the EU’s centralized online portal and database for the submission, assessment, authorization, and public transparency of clinical trials conducted in the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e2454a158c819093b8e35f5045efb6 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1765fe7d081908087778c54c1e612 completed April 29, 2026, 3:09 a.m.
Created at: April 17, 2026, 3:08 p.m.